AudioMedica News

How Babies Use Object Permanence To Get What They Want

AudioMedica.com — Thu, 04 Aug 2022 16:35:58 +0000

How Babies Use Object Permanence To Get What They Want 2022: A report from the journal: Pediatric Physical Therapy Regina Harbourne PhD, PT, PCS, FAPTA, Associate Professor in the Department of Physical Therapy at Rangos School of Health Sciences, in …

Which Tasks Most Influence Pediatric PT Productivity, Effectiveness?

AudioMedica.com — Tue, 31 Dec 2019 15:41:01 +0000

From: January 2020 Edition of Pediatric Physical Therapy journal:

CINCINNATI—Julie Badylak PT and Rebecca Durham Reder OTD, OTR/L from Cincinnati Children’s Hospital discuss the findings of their team’s report in the journal Pediatric Physical Therapy on the assessment of tasks …

Can Initial Radiotherapy Improve Survival with Prostate Cancer?

AudioMedica.com — Fri, 20 Jul 2018 17:27:51 +0000

CHICAGO—Patients with newly-diagnosed hormone-sensitive metastatic prostate cancer (mPC) who had prostate radiotherapy (RT) before their androgen deprivation therapy (ADT) lived longer than those treated with standard ADT alone in a retrospective analysis—the largest single-center experience to date of primary tumor-directed …

Geriatric Assessment Improved Outcomes for Older Patients with Cancer

AudioMedica.com — Wed, 11 Jul 2018 12:19:01 +0000

CHICAGO—A “cluster randomized controlled trial” of treatment for patients with advanced cancers found that the use of standardized geriatric assessments significantly increased the number and quality of discussions about age-related concerns in comparison with usual care and also resulted in …

Subcutaneous Daratumumab “Potential Game Changer” for Multiple Myeloma

AudioMedica.com — Mon, 15 Jan 2018 18:31:55 +0000

ATLANTA—Subcutaneous administration of the anti-CD 38 monoclonal antibody daratumumab could help more patients get this emerging therapy more easily for their advanced or recently-diagnosed multiple myeloma according to research reported from the Pavo study at the 2017 American Society of …

Prostate Genomics—Which Patients Will Die?

AudioMedica.com — Thu, 20 Apr 2017 13:04:39 +0000

MILAN, Italy—Genomic profiling could help reduce the risk of over-treatment in primary prostate cancer (PC) by identifying patients and healthy individuals whose genes put them at greatest risk of developing dangerous disseminated disease said Norman J Maitland PhD, Professor of …

Gene Assay Predicts Which Patients Need Radiation After Prostatectomy

AudioMedica.com — Tue, 18 Apr 2017 10:11:26 +0000

ARTICLE

MILAN, Italy—Genomic testing combined with clinical assessment could be the best way to identify patients with prostate cancer who can benefit from early radiotherapy after prostatectomy, according to a study in The Lancet Oncology reported at the European Multidisciplinary …

Active Surveillance Better for Which Renal Cell Cancers?

AudioMedica.com — Mon, 17 Apr 2017 22:15:34 +0000

April 15, 2017

Active Surveillance for Renal Cell Cancer

MILAN, Italy—Criteria for withholding aggressive therapies early in the course of renal cell cancer were updated at the 2016 European Multidisciplinary Meeting on Urological Cancers (EMUC) by Phillip M Pierorazio …

Nuclear War: The Facts Today

AudioMedica.com — Thu, 09 Feb 2017 00:12:12 +0000

Hans Kristensen, Director of the Nuclear Information Project, Federation of American Scientists, Washington DC and co-author of “The Growing Threat of Nuclear War and the Role of the Health Community” (World Medical Journal, 2016) tells Peter Goodwin why we need …

Competitive and Leisure Sports: Recommendations to Minimise Cardiovascular Risk

AudioMedica.com — Sun, 28 Aug 2016 11:54:10 +0000

Audio Journal of Cardiovascular Medicine

Reporting from: 2016 European Society of Cardiology, Rome

Competitive and Leisure Sports: Recommendations to Minimise Cardiovascular Risk

ROME—Exercise benefits most patients with cardiovascular disease who can take part in leisure sports safely if they wish, …

Young Women with HER2+ Early Breast Cancer Better with Mastectomy

AudioMedica.com — Wed, 24 Aug 2016 19:07:03 +0000

Audio Journal of Oncology

Young Patients With Early Breast Cancer Live Longer With Mastectomy

September 1, 2016

Transcript of the podcast as broadcast:

PETER GOODWIN: Younger women with early breast cancer treated with mastectomy had lower mortality at 20 years …

Chimeric antigen receptor T-cell therapy rescues kids with relapsing acute lymphoblastic leukaemia

AudioMedica.com — Tue, 06 Aug 2013 10:22:17 +0000

WASHINGTON DC—A new type of immunotherapy has brought responses in children with acute lymphoblastic leukaemia in relapse who had no other options to prevent the progress of this fatal phase of the disease. At the American Association for Cancer Research…

Two-step immunotherapy brings promise in advanced ovarian cancer

AudioMedica.com — Mon, 08 Apr 2013 09:45:20 +0000

WASHINGTON DC—A new type of immunotherapy has helped patients with advanced ovarian cancer who had no other therapeutic options. In a study reported to the 2013 conference of the American Association for Cancer Research Dr Lana Kandalaft from…

Circulating free tumour DNA test could guide breast cancer therapy

AudioMedica.com — Wed, 03 Apr 2013 20:33:52 +0000

CAMBRIDGE, UK—A new blood test promises quicker assessment of treatment efficacy in patients with metastatic breast cancer. Dr Dana Tsui and colleagues from the Cancer Research UK Institute at Cambridge University report in the New England Journal of Medicine that …

Dog walking cuts breast cancer recurrence risk

AudioMedica.com — Fri, 29 Mar 2013 13:33:46 +0000

Walking a dog most days could cut down your risk of having a recurrence of breast cancer, according to research presented at the St Gallen conference on Primary Therapy of Early Breast Cancer in Switzerland — where delegates also heard …

Which patients for bisphosphonate control of breast cancer metastasis?

AudioMedica.com — Fri, 29 Mar 2013 13:31:06 +0000

ST GALLEN, SWITZERLAND—Bisphosphonates have an important part to play in managing breast cancer according to research reported at the 2013 St Gallen conference on “Primary Therapy of Early Breast Cancer”. Professor Robert Coleman…

Is breast cancer screening oversold?

AudioMedica.com — Fri, 29 Mar 2013 13:28:44 +0000

ST GALLEN, SWITZERLAND—The controversy about the effectiveness of mammographic screening was aired at the 2013 conference on “Primary Therapy of Early Breast Cancer” by Dr Donald Berry of the University of Texas M D Anderson Cancer Center in Houston. While …

Low risk prostate cancer: scope and benefits from reducing overtreatment

AudioMedica.com — Sun, 24 Mar 2013 15:56:19 +0000

ORLANDO, FLORIDA—Patients with low-risk prostate cancer are more likely to die with their disease than of it, according to Dr Ayal Aizer from the Brigham and Women’s Hospital, the Dana-Farber Cancer Institute and Harvard University in Boston, MA — a …

Enzalutamide in metastatic castration resistant prostate cancer: over 75s benefit too

AudioMedica.com — Sun, 24 Mar 2013 15:54:24 +0000

ORLANDO, FLORIDA—Men over 75 were safely and effectively treated for their metastatic castration-resistant prostate cancer with the androgen receptor inhibitor enzalutamide in the Phase III AFFIRM study reported at the 2013 Genitourinary Cancers…

Low risk localized prostate cancer: no harm from waiting!

AudioMedica.com — Sun, 24 Mar 2013 15:49:48 +0000

ORLANDO, FLORIDA—A decision to delay surgery or radiotherapy for early prostate cancer is in the best interests of most patients according to research presented to the 2013 Genitourinary Cancers Symposium by Dr Andrew Loblaw from the Sunnybrook Health Sciences Centre …

Androgen blockade: 18 as good as 36 months in radiotherapy-treated prostate cancer

AudioMedica.com — Sun, 24 Mar 2013 15:47:48 +0000

ORLANDO, FLORIDA—Patients receiving radiotherapy for high-risk node-negative prostate cancer benefit as much from 18 months of androgen blockade as from the usual 36 months — but have fewer side effects — according to study findings announced at the 2013 ASCO …

MDFM New Year Special: Best of 2012

AudioMedica.com — Thu, 10 Jan 2013 07:44:51 +0000

– DENGUE FEVER: Vaccine gives some protection against three out of four virus serotypes.

Other headlines
– Breast cancer: “hidden HER2 positivity” detected by gene sequencing.
– Acute myeloid leukaemia: FLT 3 ITD mutation marks patients who can benefit from …

MDFM Christmas Edition: Best of 2012

AudioMedica.com — Mon, 31 Dec 2012 12:55:41 +0000

– HTA: Renal denervation lowers blood pressure independently of drugs
Other headlines
– CML:patients with T 315 I mutation respond to ponatinib

– Eat, drink and be merry: tomorrow you won’t die if you take exercise.

[audio:https://www.audiomedica.com/podcasting/mdfm/121227ChristmasMDFMLoRes.mp3]…

Young adults less likely to be diagnosed with hypertension than over 60s

AudioMedica.com — Mon, 31 Dec 2012 12:51:01 +0000

LOS ANGELES—Half of young adults who had multiple, elevated, blood pressure results on recent outpatient visits to the doctor, went home without a hypertension diagnosis. Research presented at the 2012 American Heart Association meeting showed, after four years of trips …

More cardiac deaths in the winter — no matter the climate

AudioMedica.com — Mon, 31 Dec 2012 12:49:10 +0000

LOS ANGELES—Regardless of climate, there are more deaths from heart-related issues in winter-time than in the summer. Results from a 12-year US population based study with over 220,000 people were presented at the American Heart Association meeting in Los Angeles …

Aging signs predict coronary risk independently of chronological age

AudioMedica.com — Mon, 31 Dec 2012 12:46:18 +0000

LOS ANGELES—Looking older than your chronological age is a risk factor for cardiovascular disease — at least among white Caucasians — according to a study of over ten thousand Danish people from the general population who were…

UK TACT2 trial confirms chemotherapy is highly effective in early beast cancer

AudioMedica.com — Tue, 18 Dec 2012 23:23:16 +0000

SAN ANTONIO, TEXAS—The UK TACT2 trial, looking at over 4 000 patients with early breast cancer, has confirmed that modern chemotherapy is very effective, and continues to contribute to very high cure rates. Professor David Cameron of Edinburgh University explains …

Chronic myeloid leukaemia: third generation TKI, ponatinib, succeeds against the T 315 I mutation

AudioMedica.com — Tue, 18 Dec 2012 23:20:42 +0000

ATLANTA, GEORGIA—A “third generation” tyrosine kinase inhibitor — ponatinib — has succeeded in controlling chronic myeloid leukaemia and Philadelphia-positive acute lymphoblastic leukaemia in patients who have the feared T 315 I mutation — which has prevented…

Younger than 35 with breast cancer: always consider neoadjuvant chemotherapy

AudioMedica.com — Tue, 18 Dec 2012 23:18:31 +0000

SAN ANTONIO, TEXAS—Women with breast cancer under the age of 35 respond very well to neo-adjuvant chemotherapy as the first line of attack against their disease, according to research from the German Breast Group presented at the 2012 San Antonio …

Acute promyelocytic leukaemia: arsenic better than chemotherapy to combine with retinoic acid?

AudioMedica.com — Tue, 18 Dec 2012 22:45:40 +0000

ATLANTA, GEORGIA—Arsenic could play a key role in perfecting gentle but curative regimens for acute promyelocytic leukaemia, according to Italian researchers reporting to the 2012 American Society of Hematology annual meeting. Professor Francesco Lo Coco…

New drug looks very promising in high risk chronic lymphocytic leukaemia

AudioMedica.com — Tue, 11 Dec 2012 21:25:13 +0000

ATLANTA, GEORGIA—The new tyrosine kinase ibrutinib has shown “profound activity” in patients with chronic lymphocytic leukaemia—according to research presented at the American Society of Hematology annual meeting. Dr Jan Burger from the MD Anderson Cancer Center…

Local or regional breast cancer recurrences mandate adjuvant chemotherapy

AudioMedica.com — Tue, 11 Dec 2012 20:33:58 +0000

SAN ANTONIO, TEXAS—Patients with local or regional recurrences of breast cancer, should be treated with chemotherapy as well as surgery and…

Lowering hematocrit below 45 per cent protects against clotting risk in patients with polycythemia vera — randomized study finding

AudioMedica.com — Tue, 11 Dec 2012 20:22:01 +0000

ATLANTA, GA—Solid confirmation of target hematocrit to minimise clotting risks in polycythemia vera has been presented at the American Society of Hematology annual meeting and simultaneously published in the…

Breast cancer: less radiotherapy in fewer hospital visits is just as good for preventing relapse

AudioMedica.com — Tue, 11 Dec 2012 20:15:05 +0000

SAN ANTONIO, TEXAS—Three weeks of radiotherapy rather than five — and lower overall doses of radiation — were just has as effective for treating breast cancer in the UK START trial conducted among 4451 women with ten-year follow-up data presented …

Dengue vaccine is safe and effective — but not against all virus serotypes

AudioMedica.com — Tue, 11 Dec 2012 20:11:50 +0000

ATLANTA—Results from the first large study of a vaccine for dengue fever — in 4000 Thai children — show that it is safe to use and effective — raising immunity to three out of the four “serotypes” of this mosquito-borne …

Schistosomiasis: water, sanitation and hygiene together with donated praziquantel make elimination possible

AudioMedica.com — Tue, 27 Nov 2012 21:46:06 +0000

ATLANTA—Schistosomiasis — also known as bilharzia — could be eliminated from Africa and elsewhere by using two actions together: making simple improvements in water-supply sanitation and hygiene and…

Malaria vaccine prevents one third of malaria cases at 12 months

AudioMedica.com — Tue, 20 Nov 2012 11:41:27 +0000

ATLANTA—Efficacy of the RTS,S malaria vaccine for children — vaccinated between six and 12 weeks age — checked-in at around 30 per cent in preliminary findings from Africa released at the American Society of Tropical Medicine and Hygiene conference by …

GAUSS STUDY: New alternative for LDL lowering in patients intolerant to statins

AudioMedica.com — Fri, 16 Nov 2012 17:55:24 +0000

LOS ANGELES—A more powerful back-up drug for patients intolerant to statins was announced at the American Heart Association 2012 Scientific Sessions. A monoclonal antibody called: AMG 145 against a protein found to regulate LDL receptor activity — the PCSK 9 …

Pregnancy hormone helps hospitalised patients with acute heart failure

AudioMedica.com — Fri, 16 Nov 2012 17:49:21 +0000

LOS ANGELES—A recombinant form of the human hormone relaxin — active in pregnancy to optimise the mother’s cardiovascular capacity — may help patients hospitalised for acute heart failure, according to findings discussed at the American Heart Association’s 2012 Scientific Sessions …

Direct infusions of HDL to prevent re-infarction in patients with acute coronary syndromes

AudioMedica.com — Fri, 16 Nov 2012 17:40:19 +0000

LOS ANGELES—Direct infusions of human HDL — to speedily boost HDL levels —could be an answer to preventing re-infarction in patients who’ve just had a heart attack and are at high risk of having another, according to conclusions from a …

Important new role for aspirin: prevention of recurrent thromboembolism: ASPIRE findings

AudioMedica.com — Mon, 12 Nov 2012 10:36:45 +0000

LOS ANGELES—Aspirin has a new role: in preventing recurrent thromboembolism among patients who are not candidates for anti-coagulation — according to conclusions from the ASPIRE study reported to the American Heart…

Polypill—even better for coronary prevention among those at high risk

AudioMedica.com — Mon, 12 Nov 2012 10:33:38 +0000

LOS ANGELES—The “polypill” — a multi-drug pill — combining diuretic, ACE inhibitor, beta-blocker, statin and aspirin — brings even more benefit when it’s targeted at patients who are at elevated coronary risk rather than being used as a general “insurance” …

CABG better than pci in patients with diabetes and multi-vessel coronary disease

AudioMedica.com — Sat, 10 Nov 2012 12:43:55 +0000

LOS ANGELES—The optimal revascularisation strategy for patients with diabetes and multi-vessel coronary disease was confirmed to be coronary artery bypass grafting rather than PCI at the American Heart Association 2012 Scientific Sessions…

Beyond Legs and Arms For Afghanistan: Disability A Resource Not A Liability

AudioMedica.com — Tue, 25 Sep 2012 20:01:40 +0000

LONDON—A man with no legs and only one arm and a boy crippled by polio have been instrumental in steering a Red Cross team’s work in Afghanistan. The ICRC’s head of Orthopaedics in Kabul, Alberto Cairo, was invited by …

Ethnic lifestyle and diet differences have a big impact on health

AudioMedica.com — Mon, 24 Sep 2012 09:46:22 +0000

LONDON—The health impact of diet and physical activity may play a part in the marked ethnic differences in type 2 diabetes and cardiovascular disease in the UK according to research reported at the London School of Hygiene & Tropical Medicine. …

Patient power improves health systems and saves cost

AudioMedica.com — Mon, 24 Sep 2012 09:44:02 +0000

LONDON—People are now routinely using the internet to find out about health conditions and to share their own experiences with others with similar diagnoses. This is a radical change in how people experience illness. Health professionals and policy makers have …

Rio Conference on Sustainable Development: “Health Should Be Top Priority”

AudioMedica.com — Sun, 29 Jul 2012 12:05:56 +0000

RIO DE JANEIRO and LONDON—A call for action on global health has been made in an article published by The Lancet medical journal about the United Nations Conference on Sustainable Development held in Rio de Janeiro. Issues which degrade the …

One in 20 hospital deaths are preventable: British Medical Journal research

AudioMedica.com — Wed, 11 Jul 2012 12:37:39 +0000

LONDON—One in twenty deaths in English hospitals could be prevented according to research published in the British Medical Journal Quality and Safety. Dr Helen Hogan of the London School of Hygiene & Tropical Medicine and her colleagues studied the causes …

Family planning: central role in global development – Lancet series

AudioMedica.com — Tue, 10 Jul 2012 12:44:50 +0000

LONDON—Family planning is a key priority for fulfilling global development goals, according to researchers writing in a special series of The Lancet medical journal coinciding with the London Summit on Family Planning. Peter Goodwin hears from one of the Lancet …

ASCO 2012 ANNUAL MEETING: Outgoing ASCO President Michael Link Comments On Key New Clinical Research Findings

AudioMedica.com — Mon, 11 Jun 2012 13:34:09 +0000

CHICAGO—The outgoing president of ASCO, Dr Michael Link from Stanford University School of Medicine in California, answers questions from Peter Goodwin about the progress achieved in cancer clinical science during his year in office. He talks specifically about new research …